DOI:
10.1055/s-00000031
Klinische Monatsblätter für Augenheilkunde
LinksClose Window
References
Pochopien M, Beiderbeck A, McEwan P. et al.
Cost-effectiveness of fluocinolone acetonide implant (ILUVIEN®) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies.
BMC Health Serv Res 2019;
19: 22
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.